Literature DB >> 11461179

Chronic fatigue syndrome: neurological findings may be related to blood--brain barrier permeability.

A C Bested1, P R Saunders, A C Logan.   

Abstract

Despite volumes of international research, the etiology of chronic fatigue syndrome (CFS) remains elusive. There is, however, considerable evidence that CFS is a disorder involving the central nervous system (CNS). It is our hypothesis that altered permeability of the blood-brain barrier (BBB) may contribute to ongoing signs and symptoms found in CFS. To support this hypothesis we have examined agents that can increase the blood-brain barrier permeability (BBBP) and those that may be involved in CFS. The factors which can compromise the normal BBBP in CFS include viruses, cytokines, 5-hydroxytryptamine, peroxynitrite, nitric oxide, stress, glutathione depletion, essential fatty acid deficiency, and N-methyl-D-aspartate overactivity. It is possible that breakdown of normal BBBP leads to CNS cellular dysfunction and disruptions of neuronal transmission in CFS. Abnormal changes in BBBP have been linked to a number of disorders involving the CNS; based on review of the literature we conclude that the BBB integrity in CFS warrants investigation. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11461179     DOI: 10.1054/mehy.2001.1306

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  6 in total

1.  Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.

Authors:  L V Clark; M Buckland; G Murphy; N Taylor; V Vleck; C Mein; E Wozniak; M Smuk; P D White
Journal:  Clin Exp Immunol       Date:  2017-10-11       Impact factor: 4.330

Review 2.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

3.  Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses.

Authors:  Warren Tate; Max Walker; Eiren Sweetman; Amber Helliwell; Katie Peppercorn; Christina Edgar; Anna Blair; Aniruddha Chatterjee
Journal:  Front Neurol       Date:  2022-05-25       Impact factor: 4.086

4.  The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Julian A G Glassford
Journal:  Front Physiol       Date:  2017-02-17       Impact factor: 4.566

5.  A Natural History of Disease Framework for Improving the Prevention, Management, and Research on Post-viral Fatigue Syndrome and Other Forms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Shennae O'Boyle; Luis Nacul; Flavio E Nacul; Kathleen Mudie; Caroline C Kingdon; Jacqueline M Cliff; Taane G Clark; Hazel M Dockrell; Eliana M Lacerda
Journal:  Front Med (Lausanne)       Date:  2022-01-28

Review 6.  A Molecular Neurobiological Approach to Understanding the Aetiology of Chronic Fatigue Syndrome (Myalgic Encephalomyelitis or Systemic Exertion Intolerance Disease) with Treatment Implications.

Authors:  Jean A Monro; Basant K Puri
Journal:  Mol Neurobiol       Date:  2018-02-06       Impact factor: 5.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.